Pablo Tebas of the Perelman School of Medicine said that in spite of some reports of allergic reactions to the COVID-19 vaccine, the rareness of these events makes it still worth pursuing vaccination. With patients dying daily, “the risk of [getting the vaccine] in a controlled environment is much less, orders of magnitude less, than getting COVID,” he said.